ETP on Saxo Healthcare Innovation Select Equity NTR 129209210 / CH1292092108
21.09
CHF
0.10
CHF
0.48 %
15:39:34
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 20.79 CHF | -0.18 CHF | -0.87 % |
|---|
| Vortag | 20.97 CHF | Datum | 14.08.2026 |
ETP on Saxo Healthcare Innovation Select Equity NTR Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 26.36% | |
| 21shares Morpho ETP | CH1506167027 | 4.26% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 3.46% | |
| 21Shares Stellar ETP | CH1109575535 | 2.48% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -1.64% | |
| 21Shares Aave ETP | CH1135202120 | -9.44% | |
| 21Shares Injective Staking ETP | CH1360612134 | -12.23% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | -14.70% | |
| 21Shares Jupiter ETP | CH1480821383 | -21.52% | |
| 21Shares XDC Network ETP | CH1464217285 | -21.85% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 74.50% | |
| 21shares Morpho ETP | CH1506167027 | 65.53% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 57.01% | |
| 21Shares Injective Staking ETP | CH1360612134 | 36.26% | |
| 21Shares Ondo ETP | CH1396389921 | 23.98% | |
| 21Shares Bittensor ETP | CH1495416971 | 21.06% | |
| 21Shares Pendle ETP | CH1495416997 | 11.98% | |
| 21Shares Jupiter ETP | CH1480821383 | 9.04% | |
| 21Shares Raydium ETP | CH1480821391 | 0.65% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | -7.44% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -0.96% | |
| 21Shares Binance BNB ETP | CH0496454155 | -30.98% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -43.92% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -47.38% | |
| 21Shares Bitcoin ETP | CH0454664001 | -48.10% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -68.89% | |
| 21Shares XDC Network ETP | CH1464217285 | -69.88% | |
| 21Shares Dogecoin ETP | CH1431521033 | -70.36% | |
| 21Shares Injective Staking ETP | CH1360612134 | -72.95% | |
| 21Shares Sui Staking ETP | CH1360612159 | -82.88% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 70.68% | |
| 21Shares Stellar ETP | CH1109575535 | 61.83% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 51.17% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 26.00% | |
| 21Shares Binance BNB ETP | CH0496454155 | 11.31% | |
| 21Shares Sui Staking ETP | CH1360612159 | -19.60% | |
| 21Shares Injective Staking ETP | CH1360612134 | -77.24% |
Fundamentaldaten
| Valor | 129209210 |
| ISIN | CH1292092108 |
| Emittent | LEONTEQ SECURITIES |
| Aufgelegt in | Switzerland |
| Auflagedatum | 30.09.2025 |
| Kategorie | Branchen: Biotechnologie |
| Währung | CHF |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 05.08.2026 |
Anlagepolitik
So investiert der ETP on Saxo Healthcare Innovation Select Equity NTR: The objective of this instrument is to provide exposure to companies advancing biotechnology, genomics, and personalised healthcare solutions. The selection includes firms engaged in genetic research, diagnostics, life-science tools, and innovative biopharmaceutical development. The instrument seeks to reflect the long-term potential of healthcare innovation as a driver of improved medical outcomes and industry transformation. Returns may be influenced by regulatory decisions, clinical results, ethical considerations, and market conditions.
ETP Performance: ETP on Saxo Healthcare Innovation Select Equity NTR
| Performance 1 Jahr | - | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |